Hypha exhibits at 3rd New Perspectives in DMPK: the impact of drug design
Hypha will showcase its expertise in DMPK metabolite synthesis at the 3rd New Perspectives in DMPK: the impact of drug design, 8th-9th February 2016 at the Royal Society of Chemistry at Burlington House, London.
Hypha are experts in producing up to gram amounts of metabolites that are hard to make synthetically. Hypha’s microbial system mimics mammalian metabolism with a very high success rate and performs difficult reactions including aliphatic hydroxylations and glucuronidations.
Furthermore, Hypha also offers MetID solutions that make use of the latest NRM technology.
We look forward to seeing you in London!